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CASE REPORT
A 53-year old female was referred by her local general 
medical practitioner to an oral medicine specialist for the 
management of a persistent ulcer on the left side of her tongue. 
The lesion had been present for at least three months and 
was not responding to treatment by topical antiseptic agents. 
The earlier removal of a molar in close proximity to the lesion, 
in an attempt to exclude the possibility of traumatic ulceration, 
had also yielded no beneficial effects. Upon examination, 
the patient appeared clinically healthy but presented with a 
history of emphysema due to chronic cigarette smoking. The 
emphysema was currently being managed by oral inhalation 
steroids. Even though smoking cessation had previously been 
advised, she failed to comply and was currently still smoking 
more than 10 cigarettes per day. 
Her intraoral examination revealed signs of a healing extraction 
socket in the lower left molar area and brown staining of 
the dorsal surface of the tongue. A 1.5 x 1.5cm ulcer with 
rolled margins and signs of induration was noted on the left 
lateral surface of the tongue opposite the left lower first molar 
(Figure 1). Interestingly, no detectable lymphadenopathy 
was noted. Based on the history and clinical findings, a 
differential diagnosis of neoplasia, tuberculosis or chronic 
trauma associated ulceration was made. 
An incisional biopsy that included the margins of the lesion 
was carried out under local anaesthesia to confirm the 
clinical diagnosis. At the same time, the patient was advised 
to reduce smoking to decrease her cancer risk as well as to 
the improve healing of the biopsy site. The histopathologic 
examination of the biopsy revealed ulcerated mucosa with 
a florid chronic granulomatous infiltrate in the submucosa. 
Whilst there were no signs of caseating necrosis, the 
presence of a few multinucleated (typical tuberculosis-
associated) Langhans-type giant cells was, however, noted 
and the granulomatous inflammation showed infiltration 
by lymphocytes and numerous eosinophils. Of pertinent 
interest was the fact that the granulomas extended 
deeply into the submucosa and were wedged between 
the skeletal muscle fibres at the base of the specimen 
(Figure 2). The presence of eosinophils could be attributed 
to chronic skeletal muscle damage. No signs of epithelial 
dysplasia or neoplasia were noted. Ziehl-Neelsen staining 
was negative for mycobacterial species (Figure 3) and 
Periodic acid-Schiff staining did not expose signs of fungal 
infection. Immunoperoxidase studies for cytokeratins 
were negative, thus ruling out a malignant squamous 
infiltrate which could have been masked by the dense 
granulomatous inflammation. The histological diagnosis 
of chronic granulomatous inflammation, that could not be 
further specified, was made.
 
Due to the inconclusive nature of the histopathological 
findings, additional investigations were requested to exclude 
systemic disease and specifically tuberculosis. This revealed 
the following significant findings: An ESR of 58; normal full 
blood and differential white blood counts; negative test for 
HIV; negative results for syphilis; plain chest radiographs 
indicating a miliary pattern of lung calcifications (also noted 
on radiographs taken two years earlier); and high resolution 
computer tomography (CT) showing lung calcifications that 
were considered non-specific by the radiologists but were 
deemed to indicate a possible infectious granulomatous 
disease. The differential diagnosis was consequently altered 
to include tuberculosis, varicella pneumonia and sarcoidosis.
MT Peck: 1. BChD, MScDent, MRD RCSEd(Perio), MChD(OMP). 
Division of Oral Medicine and Periodontics, Faculty of Dentistry, 
University of the Western Cape.
J hille: 2. DDS, MDent, FCPath(SA). Division of Oral Pathology, 
Faculty of Dentistry, University of the Western Cape & National 
Health LaboratoryService, Tygerberg.
a snyman: 3. MBChB(Stell). Private Practice, Cape Town.
wP Dreyer: 4. BDS, HDipDent, PhD, FCD(SA)OMP. Division of Oral 
Medicine and Periodontics, Faculty of Dentistry, University of the 
Western Cape; Professor Emeritus, Stellenbosch University.
corresponding author
wP Dreyer: 
 PO Box 1285, Sedgefield, 6573; e-mail wpdreyer@telkomsa.net
saDJ april 2015, vol 70 no 3 p120 - p122
MT Peck1, J hille2, a snyman3, wP Dreyer4
Oral medicine case book 68: 
Oral ulceration caused by rifampicin-
resistant tuberculosis
ACRONYMS
DNA:   Deoxyribonucleic acid  
HIV:   Human immunodeficiency virus
INH:   Isoniazid
MDR-TB: Multidrug-resistant tuberculosis
NAAT:   Nucleic acid amplification test
PCR:    Polymerase chain reaction
RIF:   Rimfampicin
RMR-TB: Rimfampicin-resistant tuberculosis
RNA:   Ribonucleic acid
TB:   Tuberculosis
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Based on these investigations, the original paraffin-embedded tongue tissue 
sample was subjected to further analysis using Xpert® MTB/RIF (Cepheid, 
Sunnyvale, CA, USA) which is a cartridge-based, automated diagnostic 
test using a polymerase chain reaction (PCR) based assay. The results 
confirmed the presence of tuberculosis DNA from a strain that was resistant 
to rifampicin and consequently a final diagnosis of an oral ulcer secondary 
to rifampicin-resistant tuberculosis (RMR-TB) was made.
 
As a result of this diagnosis, the patient was promptly referred back to her 
GP who, following protocol, referred her for treatment at her local community 
health centre. Here she received four months’ worth of intensive multidrug-
resistant tuberculosis therapy that included a cocktail of medication 
including kanamycin (injectable), moxifloxacin, pyrazinamide, ethambutol and 
ethionamide. At her four month follow-up appointment, she reported feeling 
better and the original oral ulcer showed a marked decrease in size (Figure 
4). Upon request from her treating physician, a second biopsy of the site was 
taken at this time to exclude active disease. The histopathology revealed the 
presence of residual non-caseating granulomas containing Langhans giant 
cells and lymphocytes within the deeper submucosa (Figure 5). The Ziehl-
Neelsen stain was again negative for mycobacterial species, however, the 
possible diagnosis of (residual) tuberculosis was suggested. The patient was 
subsequently requested to return routinely in order to monitor the oral lesion 
as well as to detect the possible development of any new lesions. Because 
of the prolonged treatment time associated with this condition, she was still 
undergoing anti-tuberculosis therapy at the time of publication. 
DISCUSSION
Oral lesions caused by the bacillus Mycobacterium tuberculosis may arise 
as primary lesions or, more commonly, as lesions secondary to pulmonary 
tuberculosis. The escalation of tuberculosis (TB) in many areas of the world, 
and especially in the Western Cape of South Africa, could produce an increase 
in the prevalence of oral lesions.1 Multidrug-resistant TB is also becoming more 
prevalent and oral lesions caused by multidrug resistant strains of the bacillus 
should thus, at least theoretically, also be on the rise. However, the present 
case is one of the first to be reported.
Rifampicin-resistant tuberculosis (RMR-TB) is a rapidly emerging form of TB, 
characterised by resistance to the anti-TB drug, rifampicin (RIF). RIF is an 
important first-line drug in the treatment of TB and acts by arresting the DNA-
directed RNA synthesis of M. tuberculosis.2 Once regarded as rare, RMR-TB 
appears to be on the rise, especially in areas like the Western Cape, South 
Africa.3,4 This is significant, since multidrug-resistant TB (MDR-TB) is often 
preceded by the acquisition of resistance to either isoniazid (INH) or RIF.4-6 
Individuals co-infected with TB and HIV (human immunodeficiency virus), 
HIV infected individuals on antiretroviral therapy and those with a previous 
history of TB treatment appear to be at increased risk for acquiring RMR-TB 
infection.3-5 Alcohol abuse is probably  another risk factor associated with the 
disease.4 Patients in countries with a high usage of rifampicin-type drugs for 
the management of bacterial infections, also appear to be at increased risk.7 
As with other forms of tuberculosis, RMR-TB is thought to be transmitted 
via close contact and at least three different studies, from disparate regions, 
confirm this tendency.3-5 In the case presented above, the only identifiable 
TB contact was a close relative who had been treated successfully for TB 
15 years previously.
The mechanism of RIF resistance has recently been studied. Pang et al 
(2013) showed that specific genetic mutations located in the 81-bp region 
(RIF resistance-determining region) as well as the increased transcription of 
several RIF-related efflux pumps, may be responsible for a large percentage 
of the RIF-resistant TB strains currently seen.2 Efflux pumps are primitive 
transport proteins located in the cytoplasmic membrane of most cells, 
including bacteria. These pumps are involved in the extrusion of intracellular 
substances into the external environment and are often associated with the 
efflux of multiple substrates, including antibiotics.8 Although their physiological 
function is not completely understood, the over-expression of efflux pumps is 
thought to be a major reason for antibiotic resistance. This resistance may not 
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Figure 1: At the initial visit an indurated ulcer with rolled 
margins, measuring 1.5 x 1.5 mm, was noted on the left 
lateral side of the tongue.
Figure 2: A medium-power H and E stained view 
revealed the presence of a dense chronic granulomatous 
infiltrate in the deep submucosa and showed part of the 
lesion to be wedged between skeletal muscle bundles 
at the base of the specimen.
Figure 3: Ziehl-Neelsen staining failed to reveal the presence 
of mycobacteria within or adjacent to the non-caseating 
granulomas. Note the large Langhans-type multinucleated 
giant cell in the upper left centre of this high-power view.
Figure 4: The lesion as seen at the follow-up visit 
four months post-biopsy and following multidrug TB 
treatment. The lesion was much improved, but not 
completely healed.
Figure 5: A medium-power view of the second biopsy. 
The presence of residual non-caseating granulomas was 
noted in the deep submucosa.
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be antibiotic specific but may also incur resistance to other 
substances, such as dyes, detergents, and disinfectants 
(including triclosan). Although one might presume that 
over-expression of these pumps may occur as a result of 
exposure to antibiotic stresses, this may not be the case. 
It is presupposed that over-expression may occur due 
to mutations of local suppressor genes resulting in the 
development of bacterial species with a high efficacy of 
resistance to a number of substances. This may also explain 
the high intrinsic antibiotic resistance of certain bacterial 
species.8 The clinical significance of these antibiotic resistant 
species therefore warrants the use of a broad spectrum of 
drugs to effect a significant clinical change.
DIAGNOSIS AND TREATMENT
The diagnosis of drug-resistant TB is based on clinical and 
laboratory examination. Once TB is suspected, based on 
clinical, histological and/or microbiological grounds, two 
types of tests are used to evaluate drug susceptibility.9 
These include WHO-endorsed solid or liquid culture-based 
tests, such as solid agar or Bactec MGIT 960 (Becton-
Dickson, Sparks, MD, USA), and molecular based tests that 
include nucleic acid amplification (NAAT).9 Culture based 
tests assess the inhibition of M. tuberculosis growth in the 
presence of antibiotics10 and even though they are regarded 
as the diagnostic gold standard, culture based tests suffer 
from a number of disadvantages. These include the time 
required (minimum 21 days), the specialised equipment 
needed and the lack of infrastructure in most resource-poor 
settings.8-9 In the above case, culture based tests were not 
possible due to the limited size of the tissue biopsy.
Unlike culture-based tests, NAATs allow much faster 
processing times, with results often available within two 
hours.9 The most commonly used NAAT is Xpert® MTB/
RIF (Cepheid, Sunnyvale, CA, USA). This is a polymerase 
chain reaction test that simultaneously diagnoses TB and 
RIF resistance, and is now endorsed by the WHO as a first 
investigation for patients suspected of having drug resistant 
tuberculosis. Although rapid, the disadvantage of Xpert® 
MTB/RIF, is that is does not test for INH resistance. This 
may result in patients suffering from RIF mono-resistant-TB 
being overtreated.6 Another major disadvantage of Xpert® 
MTB/RIF is that it is associated with inconsistent results, 
especially for extrapulmonary cases.9,11 A culture based 
test or another type of NAAT test would then be indicated 
to confirm the diagnosis.
TREATMENT
The management of patients suffering from RMR-TB 
is complex and is not fully standardized. International 
guidelines offer different opinions with some advocating 
management similar to that of MDR-TB. This consists of a 
backbone of later generation fluoroquinilone as well as an 
injectable aminoglycoside, together with any first line drug 
to which the bacterium is susceptible. In addition to this, an 
oral bacteriostatic second-line TB drug should also be used. 
Treatment is initiated by an intensive phase of injectable 
medication that might last up to 18 months with the total 
duration of treatment usually extending up to 24 months.3-5 
Because of the prolonged treatment regimen, patients have 
to be monitored frequently for compliance, adverse drug 
reactions and drug interactions. The treatment outcome 
for RMR-TB varies according to geographical location, 
regimen choice and duration of treatment. Curative rates of 
up to 67% have been recorded but may be influenced by 
the factors mentioned above.5
CONCLUSION
The case presented above has clinical significance for 
the oral health care practitioner. Oral lesions may be 
the first sign of systemic disease and, as in this case, 
a non-healing ulcer was the only presenting sign of 
RMR-TB. Thus, although oral ulceration is common, 
and TB associated oral ulceration is a well-documented 
phenomenon, the rise of resistant TB strains warrants 
careful consideration when managing these patients. 
The varied curative rate as well as the potential for 
disease spread must be taken into account. Practitioners 
must be aware that in order to effectively manage these 
complex conditions, interaction with the appropriate 
specialists, as well as with other healthcare workers, may 
be required. An acute awareness of systemic disease is 
a prerequisite for diagnosing oral disease, especially in 
cases with potentially fatal disorders. 
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